Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 16Psoriasis 7Leukemia 5Lymphoma, Follicular 4Spondylitis, Ankylosing 3Myelodysplastic Syndromes 3Inflammation 3Asthma 3Arthritis, Juvenile 3Vasculitis 2Uveitis 2Respiratory Distress Syndrome 2Recurrence 2Prostatic Neoplasms 2Pneumonia 2Neuroblastoma 2Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myelomonocytic, Juvenile 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Granulomatosis with Polyangiitis 2Bronchiolitis Obliterans 2Arthritis, Psoriatic 2Wilms Tumor 1Temporomandibular Joint Disorders 1Stomatitis 1Spondylarthritis 1Pruritus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Metformin 7Testosterone 2Pioglitazone 2Magnetic Resonance Spectroscopy 2Inositol 2Exercise 2Ethinyl Estradiol 2Blood Pressure 2semaglutide 1maltodextrin 1drospirenone and ethinyl estradiol combination 1drospirenone 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Walking 1Vascular Stiffness 1Ultrasonography 1Triptorelin Pamoate 1Topiramate 1Tirzepatide 1Sugars 1Spironolactone 1Qsymia 1Pyruvic Acid 1Pulse Wave Analysis 1Preoperative Exercise 1Phlebotomy 1Phentermine 1Pancreaticoduodenectomy 1Orchiectomy 1Observation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolic Syndrome × Etanercept × Clear all
NCT00111956 2017-10-06

Effects of Tumor Necrosis Factor (TNF)-Alpha Antagonism in Patients With Metabolic Syndrome

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Phase 2/3 Completed
56 enrolled

Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡